Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
1.
Rev Gastroenterol Mex (Engl Ed) ; 89(3): 404-417, 2024.
Article in English | MEDLINE | ID: mdl-39033039

ABSTRACT

Acute liver failure is a rare but serious syndrome, with an incidence of approximately 2,000 to 3,000 cases per year in North America. Its pathophysiology and clinical course vary, depending on the cause of the primary liver injury, and can lead to high morbidity and mortality or the need for liver transplantation, despite available therapies. This syndrome involves excessive activation of the immune system, with damage in other organs, contributing to its high mortality rate. The most accepted definition includes liver injury with hepatic encephalopathy and coagulopathy within the past 26 weeks in a patient with no previous liver disease. The main causes are paracetamol poisoning, viral hepatitis, and drug-induced liver injury, among others. Identifying the cause is crucial, given that it influences prognosis and treatment. Survival has improved with supportive measures, intensive therapy, complication prevention, and the use of medications, such as N-acetylcysteine. Liver transplantation is a curative option for nonresponders to medical treatment, but adequate evaluation of transplantation timing is vital for improving results. Factors such as patient age, underlying cause, and severity of organ failure influence the post-transplant outcomes and survival.


Subject(s)
Liver Failure, Acute , Humans , Liver Failure, Acute/therapy , Liver Failure, Acute/etiology , Liver Failure, Acute/diagnosis , Prognosis , Liver Transplantation
3.
Rev Gastroenterol Mex (Engl Ed) ; 88(4): 392-403, 2023.
Article in English | MEDLINE | ID: mdl-38097433

ABSTRACT

Hepatitis C virus (HCV) infection is a worldwide public health problem associated with significant morbidity and mortality. In the context of liver transplantation, the demand for organs continues to exceed the supply, prompting the consideration of using organs from HCV-positive donors in HCV-negative recipients. The introduction of direct-acting antivirals (DAAs), which have demonstrated great efficacy in eradicating the virus, has made transplantation of organs from donors with HCV infection possible. The present article provides a brief review of the current evidence on the use of organs from HCV-infected patients.


Subject(s)
Hepatitis C, Chronic , Hepatitis C , Liver Transplantation , Humans , Hepacivirus , Antiviral Agents/therapeutic use , Mexico , Hepatitis C, Chronic/drug therapy , Hepatitis C, Chronic/surgery , Hepatitis C/drug therapy
4.
Arch Soc Esp Oftalmol (Engl Ed) ; 94(1): 4-11, 2019 Jan.
Article in English, Spanish | MEDLINE | ID: mdl-30270037

ABSTRACT

BACKGROUND AND OBJECTIVE: In view of the increasing bacterial resistance to antibiotics, it is necessary to determine it locally in order to serve as a guide in clinical management. The purpose of this study was to characterise the pattern of antibiotic sensitivity in cases of eye infections in a third level ophthalmological institution in Floridablanca (Colombia). MATERIALS AND METHODS: An observational cross-sectional study in which an analysis was made of the culture and antibiogram reports of specimens taken from cases of conjunctivitis, infectious keratitis, and endophthalmitis between January 2013 and June 2016. RESULTS: A total of 833 specimens were positive for bacteria. Considering both gram-positive and gram-negative microorganisms gentamicin, tobramycin, and ciprofloxacin showed high resistance rates (64.4%, 40.3%, and 29.1%, respectively). Moxifloxacin, vancomycin, imipenem, and gatifloxacin showed low percentages of resistance: 2.6%, 2.1%, 0.6%, and 0.4%, respectively. When comparing the results with previous studies in our institution, there was a decrease in sensitivity to the fourth-generation quinolones and imipenem, especially within the gram-negative ones. CONCLUSION: Fourth generation quinolones, imipenem and vancomycin continue to have a low in vitro resistance to bacteria that cause eye infections. However, there was a tendency to an increase in the resistance of gram-negative bacteria. Measures should be taken to try to control this phenomenon, and consider possible antimicrobial therapy alternatives to infections caused by these microorganisms.


Subject(s)
Conjunctivitis, Bacterial/drug therapy , Drug Resistance, Bacterial , Endophthalmitis/drug therapy , Keratitis/drug therapy , Anti-Bacterial Agents/therapeutic use , Colombia , Conjunctivitis, Bacterial/microbiology , Cross-Sectional Studies , Endophthalmitis/microbiology , Gram-Negative Bacterial Infections/drug therapy , Gram-Positive Bacterial Infections/drug therapy , Humans , Keratitis/microbiology , Microbial Sensitivity Tests
5.
J Physiol Biochem ; 75(1): 83-88, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30539499

ABSTRACT

Kaempferol is a natural flavonoid widely found in fruits, vegetables, and tea. Kaempferol possesses beneficial biological properties such as anti-inflammatory and antioxidant activities. Positive energy balance during obesity correlates with a pro-inflammatory chronic state. In this context, we hypothesized that kaempferol might promote anti-obesity effects by modulating adipogenesis and lipolytic pathways. Adipocyte viability at 24, 48, and 72 h was measured by an ATP-based assay. Pre-adipocytes (day 0) or mature adipocytes (day 12) were treated with 60 µM kaempferol until day 21 to evaluate its potential anti-adipogenic and lipolytic effect, respectively. Total lipid accumulation was assessed using Oil Red O staining assay. Gene expression was measured by RT-qPCR to evaluate the effect of kaempferol on adipogenesis and lipolysis gene expression. Our results showed a dose-dependent effect of kaempferol treatment on cell viability promoting cell death at higher than 60 µM concentration. Pre-adipocytes stimulation by 60 µM kaempferol resulted in 62% adipogenesis inhibition whereas in mature adipocytes, it reduced 39% intracellular lipid accumulation. Also, 60 µM kaempferol treatment decreased Cebpa mRNA expression when compared to control cells. In contrast, Pnpla2 and Lipe gene expression were upregulated in 3T3-L1 cells incubated with 60 µM kaempferol. In summary, our results showed that kaempferol modulates adipogenic differentiation in 3T3-L1 cells by promoting downregulation of Cebpa gene expression and decreasing lipid accumulation in mature adipocytes by its positive effects on Pnpla2 and Lipe mRNA levels. Kaempferol might display an anti-obesity effect.


Subject(s)
Adipocytes/drug effects , Adipogenesis/drug effects , Anti-Obesity Agents/pharmacology , Kaempferols/pharmacology , Lipolysis/drug effects , 3T3-L1 Cells , Adipocytes/cytology , Adipocytes/metabolism , Adipogenesis/genetics , Animals , Azo Compounds , CCAAT-Enhancer-Binding Proteins/antagonists & inhibitors , CCAAT-Enhancer-Binding Proteins/genetics , CCAAT-Enhancer-Binding Proteins/metabolism , Cell Differentiation/drug effects , Cell Survival/drug effects , Dose-Response Relationship, Drug , Gene Expression Regulation , Lipase/genetics , Lipase/metabolism , Lipolysis/genetics , Mice , RNA, Messenger/genetics , RNA, Messenger/metabolism
6.
Lupus ; 27(14): 2292-2295, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30394833

ABSTRACT

BACKGROUND: Nontraumatic acute transverse myelitis (ATM) can occur in response to infectious, inflammatory and vascular triggers; 1% of patients with systemic lupus erythematosus (SLE) develop ATM, but the mechanism remains unknown. OBJECTIVE: The objective of this case report is to describe a case of intrathecal formation of anticardiolipin antibodies (aCL) during SLE-related ATM. METHODS: A single patient analysis was conducted. RESULTS: A 26-year-old housewife was diagnosed with SLE at age 19. Circulating aCL antibodies were positive at diagnosis. At age 21, she developed an episode of severe sepsis. At 23 years of age she developed an episode of ATM that left her paraplegic with a D10 sensory level, from which she recovered partially. Three years later, she developed a clinical relapse of ATM. During that second episode, serum levels of aCL were within normal limits, while cerebrospinal fluid levels were increased, suggesting intrathecal production of aCL. CONCLUSION: Here, we present a case of a woman who developed relapsing SLE-related longitudinally extensive ATM in whom intrathecal formation of aCL was demonstrated, suggesting that local production and cross-recognition of nervous tissue by those autoantibodies may be myelopathic.


Subject(s)
Antibodies, Anticardiolipin/blood , Lupus Erythematosus, Systemic/complications , Myelitis, Transverse/diagnosis , Adult , Brain/diagnostic imaging , Female , Humans , Magnetic Resonance Imaging , Recurrence , Spinal Cord/diagnostic imaging
7.
Arch Soc Esp Oftalmol (Engl Ed) ; 93(12): 613-616, 2018 Dec.
Article in English, Spanish | MEDLINE | ID: mdl-30017419

ABSTRACT

CLINICAL CASE: A 51 year-old immunocompetent male was referred due to presenting with a large corneal ulcer with hypopyon in the right eye. Topical amphotericin B, fluconazole and moxifloxacin, as well as oral itraconazole were initially indicated. Following the report of mycotic structures on staining, topical natamycin was started. The result of the culture was reported two weeks later as, Scedosporium apiospermum (S. apiospermum), and topical voriconazole was then added. The response to treatment was very slow, and took five weeks after receiving triple therapy (natamycin, voriconazole and fluconazole) and one dose of intrastromal voriconazole, for the hypopyon to disappear. The final outcome was successful, achieving healing of the ulcer. The patient is waiting for a corneal transplant. DISCUSSION: A microbiological study is essential in patients in whom fungal keratitis is suspected. The treatment of choice against S. apiospermum is with voriconazole, but the combination of various antifungal agents may be required.


Subject(s)
Corneal Ulcer/microbiology , Eye Infections, Fungal/microbiology , Scedosporium/isolation & purification , Antifungal Agents/therapeutic use , Corneal Transplantation , Corneal Ulcer/drug therapy , Drug Therapy, Combination , Eye Infections, Fungal/drug therapy , Fluconazole/therapeutic use , Humans , Immunocompetence , Male , Middle Aged , Natamycin/therapeutic use , Voriconazole/therapeutic use
8.
Lupus ; 27(8): 1279-1286, 2018 Jul.
Article in English | MEDLINE | ID: mdl-29635997

ABSTRACT

Background and objective Acute transverse myelitis (TM) is an infrequent neurological complication of systemic lupus erythematosus (SLE). Short-term outcome varies widely between cohorts. Little is known about the epidemiology and long-term functional outcome of TM associated to SLE. Methods Patients with SLE and acute TM were identified during hospital admission, visits to the Emergency Room or the Neurology Outpatient Clinic. We evaluated ambispectively those patients with SLE presenting with clinical myelopathy and corroborated with spinal MRI. Cases were divided as partial (non-paralyzing) or complete (paralyzing). We determined long-term functional outcome as well as mortality in those patients with follow-up periods of at least five years. Results We identified 35 patients (partial, n = 15; complete, n = 20) in which complete clinical and imaging data were available (26 with follow-up ≥ 5 years). Patients with complete TM were significantly older than those with partial forms. Positive antiphospholipid antibodies were observed in 80% of patients, suggesting a possible mechanistical role. Surprisingly, functional recovery at one year was in general good; however, we observed a five-year mortality of 31% because of sepsis (in 10 cases) or pulmonary embolism (in one case). Conclusions Short-term outcome of SLE-related TM is generally good, and recurrence rate is low. However, we observed a long-term fatality rate of 31% for reasons unrelated to TM, suggesting that TM is a manifestation of severe immune dysregulation and a predictor of severity and mortality in patients with SLE.


Subject(s)
Lupus Erythematosus, Systemic/complications , Myelitis, Transverse/diagnostic imaging , Myelitis, Transverse/mortality , Adult , Azathioprine/therapeutic use , Female , Humans , Lupus Erythematosus, Systemic/drug therapy , Magnetic Resonance Imaging , Male , Mexico , Myelitis, Transverse/etiology , Prednisone/therapeutic use , Tertiary Care Centers , Young Adult
9.
Bol Asoc Med P R ; 90(4-6): 69-73, 1998.
Article in English | MEDLINE | ID: mdl-9866270

ABSTRACT

From 1983 to 1993, 30 cases of gastroschisis were managed at the Mayaguez Medical Center. Ninety percent of these patients underwent primary closure of their abdominal wall defect. Three of 30 patients (10%) required silastic or goretex silos with final closure in an average of 8 days. There was no sex predilection, the average birth weight was 2.4 kg and the mean gestational age was 36 weeks. Thirty percent had associated anomalies, the majority were intestinal atresia, and/or undescended testicles. Twenty one (70%) of infants were delivered vaginally. Nine children (30%) were delivered via cesarean section. Four cesarean sections were done solely after prenatal ultrasonic identification of gastroschisis. There was no improvement in hospital stay, complications, or days until enteral feeds were tolerated when vaginally delivered patients were compared to those born by c-sections. In seven patients mesh sheeting (Marlex) was used for closure of late hernia defects. The mean hospital stay was 50 days and the mean time to enteral feedings 20 days. All patients required postoperative mechanical ventilation for an average of 4 days. There was no mortality. Our data and review of the literature do not support gastroschisis prenatal diagnosis as a sole indication for cesarean section. Our data showed favorable prognosis for most babies. Primary fascial closure can be accomplished safely in the majority of patients. No single operative strategy is ideal for all patients, and treatment of individual defects should be tailored to the degree of visceroabdominal disproportion.


Subject(s)
Gastroschisis/epidemiology , Abnormalities, Multiple/epidemiology , Adult , Cesarean Section/statistics & numerical data , Cryptorchidism/epidemiology , Female , Fetal Diseases/diagnostic imaging , Gastroschisis/diagnostic imaging , Gastroschisis/surgery , Gestational Age , Humans , Infant, Newborn , Length of Stay , Male , Parenteral Nutrition, Total/statistics & numerical data , Pregnancy , Puerto Rico/epidemiology , Respiration, Artificial/statistics & numerical data , Retrospective Studies , Surgical Mesh/statistics & numerical data , Ultrasonography, Prenatal/statistics & numerical data
10.
Bol Asoc Med P R ; 90(4-6): 93-4, 1998.
Article in English | MEDLINE | ID: mdl-9866277

ABSTRACT

This is a case report of a newborn patient with imperforate anus, urethro-colonic fistula, perianal hamartoma, and bifid scrotum. Successful staged repair of these anomalies is described together with review of the embriology related to the case.


Subject(s)
Abnormalities, Multiple , Anus, Imperforate , Hamartoma , Perineum/abnormalities , Scrotum/abnormalities , Abnormalities, Multiple/surgery , Anus, Imperforate/surgery , Colostomy , Hamartoma/surgery , Humans , Infant, Newborn , Male , Perineum/surgery , Rectal Fistula/surgery , Rectum/embryology , Scrotum/surgery , Ureteral Diseases/surgery , Urethral Diseases/surgery , Urinary Fistula/surgery , Urinary Tract/embryology
11.
Bol. Asoc. Méd. P. R ; Bol. Asoc. Méd. P. R;90(4/6): 93-94, Apr.-Jun. 1998.
Article in English | LILACS | ID: lil-411391

ABSTRACT

This is a case report of a newborn patient with imperforate anus, urethro-colonic fistula, perianal hamartoma, and bifid scrotum. Successful staged repair of these anomalies is described together with review of the embriology related to the case


Subject(s)
Humans , Male , Infant, Newborn , Abnormalities, Multiple , Anus, Imperforate , Scrotum/abnormalities , Hamartoma , Perineum/abnormalities , Abnormalities, Multiple/surgery , Anus, Imperforate/surgery , Colostomy , Urethral Diseases/surgery , Ureteral Diseases/surgery , Scrotum/surgery , Rectal Fistula/surgery , Urinary Fistula/surgery , Hamartoma/surgery , Perineum/surgery , Rectum/embryology , Urinary Tract/embryology
12.
Bol. Asoc. Méd. P. R ; Bol. Asoc. Méd. P. R;90(4/6): 69-73, Apr.-Jun. 1998.
Article in English | LILACS | ID: lil-411398

ABSTRACT

From 1983 to 1993, 30 cases of gastroschisis were managed at the Mayaguez Medical Center. Ninety percent of these patients underwent primary closure of their abdominal wall defect. Three of 30 patients (10%) required silastic or goretex silos with final closure in an average of 8 days. There was no sex predilection, the average birth weight was 2.4 kg and the mean gestational age was 36 weeks. Thirty percent had associated anomalies, the majority were intestinal atresia, and/or undescended testicles. Twenty one (70%) of infants were delivered vaginally. Nine children (30%) were delivered via cesarean section. Four cesarean sections were done solely after prenatal ultrasonic identification of gastroschisis. There was no improvement in hospital stay, complications, or days until enteral feeds were tolerated when vaginally delivered patients were compared to those born by c-sections. In seven patients mesh sheeting (Marlex) was used for closure of late hernia defects. The mean hospital stay was 50 days and the mean time to enteral feedings 20 days. All patients required postoperative mechanical ventilation for an average of 4 days. There was no mortality. Our data and review of the literature do not support gastroschisis prenatal diagnosis as a sole indication for cesarean section. Our data showed favorable prognosis for most babies. Primary fascial closure can be accomplished safely in the majority of patients. No single operative strategy is ideal for all patients, and treatment of individual defects should be tailored to the degree of visceroabdominal disproportion


Subject(s)
Humans , Male , Female , Pregnancy , Infant, Newborn , Adult , Gastroschisis/epidemiology , Abnormalities, Multiple/epidemiology , Cesarean Section , Cryptorchidism/epidemiology , Fetal Diseases , Gestational Age , Gastroschisis/surgery , Gastroschisis , Length of Stay , Parenteral Nutrition, Total , Puerto Rico/epidemiology , Retrospective Studies , Respiration, Artificial , Surgical Mesh
13.
Am J Bot ; 85(6): 855, 1998 Jun.
Article in English | MEDLINE | ID: mdl-21715291

ABSTRACT

The pattern of morphological variation of Cocos nucifera in Mexico was statistically and numerically evaluated. Forty-one populations were analyzed, using 17 morphological fruit characters. Principal components and cluster analyses indicated four main groups of coconut populations that showed high similarity with four different genotypes recently imported into Mexico from areas that could be the origin of Mexican coconut populations. These four genotypes were evaluated with regard to the lethal yellowing disease in Jamaica and showed a differential susceptibility. Therefore it is possible to speculate upon a difference in susceptibility of the Mexican genotypes. The analysis of correlation between morphological and geographical distances showed a high positive correlation that supports: (1) historical evidence that indicates early introductions of coconut from different regions of the world, (2) that on both coasts of Mexico two different patterns of dispersal were involved: continuous and in jumps. Collectively these results suggest that the impact of the lethal yellowing disease on coconut populations will vary depending on the specific area and the origin of its coconuts.

SELECTION OF CITATIONS
SEARCH DETAIL